Paydirt
Insider filing · AVTX

Christopher Ryan Sullivan sold $449K of Avalo Therapeutics (AVTX)

Executed May 7, disclosed May 11, 4 days later.

Value, as filed
$449K
18,606 sh × $24.12
Executed
May 7
the trade date, as filed
Disclosed
May 11
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only

Returns are measured on stock purchases only.

The filer
CS Christopher Ryan Sullivan Chief Financial Officer profile →

Christopher Ryan Sullivan (Chief Financial Officer) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in Avalo Therapeutics, Inc. (AVTX). The largest single filing was $1.4M of AVTX (68,976 sh across 2 lots, as filed), executed Aug 17.

The name
AVTX Avalo Therapeutics, Inc. AVTX · Healthcare · 11 filings in 24 months ticker →

Healthcare · Avalo Therapeutics, Inc., a clinical stage biotechnology company, develops IL-1ß-based treatments for immune-mediated inflammatory diseases…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→
Other filings by Christopher Ryan Sullivan in AVTX
AVTXSALE Avalo Therapeutics, Inc. $202K
12,394 sh × $16.33
Exec Sep 16
Filed Sep 18 · 4:10 PM ET AVTXSALE Avalo Therapeutics, Inc. $179K
10,185 sh × $17.62
Exec Sep 10
Filed Sep 11 · 4:10 PM ET AVTXSALE Avalo Therapeutics, Inc. $1.4M
68,976 sh across 2 lots
Exec Aug 17
Filed Aug 19 · 4:10 PM ET AVTXSALE Avalo Therapeutics, Inc. $893K
44,300 sh across 4 lots
Exec May 6
Filed May 7 · 5:30 PM ET AVTXSALE Avalo Therapeutics, Inc. $223K
16,915 sh across 2 lots
Exec Apr 29
Filed May 1 · 5:30 PM ET AVTXSALE Avalo Therapeutics, Inc. $231K
13,679 sh across 2 lots
Exec Apr 1
Filed Apr 3 · 5:30 PM ET